In The News

SCIENCE GETS CLOSER TO UNDERSTANDING HOW A PSYCHEDELIC TRIP CHANGES THE BRAIN

The small study found evidence that a single trip may alter pathways between parts of the brain responsible for emotional regulation.

May 5, 2026

THE OPTIMISATION PROBLEM:

What Bryan Johnson’s 5-MeO-DMT Experiment Reveals About Psychedelics Going Mainstream

April 29, 2026

THE NEW EXECUTIVE ORDER (EO) ON PSYCHEDELICS—WHAT COMES NEXT?

Understanding the EO's impact on LSD, psilocybin, 5-MeO-DMT, ibogaine, MDMA.

April 27, 2026

TRUMP SIGNS ORDER TO ACCELERATE ACCESS TO PSYCHEDELIC DRUG TREATMENTS

U.S. President Donald Trump signed an executive order on Saturday intended to speed up access to medical research and treatment based on psychedelic ‌drugs. April 18, 2025

A PSYCHEDELIC SURPRISE: DMT HELPS THE BRAIN HEAL AFTER STROKE

Scientists have discovered that DMT, a natural compound found in plants and even the human brain, can dramatically reduce brain damage caused by stroke.

GROUND-BREAKING LSD MICRODOSING FOR ALZHEIMER'S STUDY

A study developed by Amanda Feilding in collaboration with experts in Geriatrics and neurodegenerative diseases from the University of Basel

Summer 2023

HOW ‘MAGIC MUSHROOMS’ COULD HELP PARKINSON’S DISEASE PATIENTS

A UCSF pilot study finds psilocybin therapy surprises, showing meaningful improvements in mood, cognition, and motor symptoms.

April 2025

PSYCHEDELICS FOR ALZHEIMER'S DISEASE-RELATED DEMENTIA: UNVEILING THERAPEUTIC POSSIBILITIES AND PATHWAYS

ScienceDirect.com

April 2024

‘MAGIC MUSHROOM’ INGREDIENT MAY DELAY AGING AND EXTEND LIFESPAN

Psilocybin, the active ingredient in psychedelic mushrooms, may have both anti-aging as well as mental health benefits.

JULY 14TH, 2025